We all know that melanoma is an epidemic. The most important factor in improving survival is early detection and surgical removal of the abnormal lesion. But there may be hope for those patients that waited too long to get checked – the FDA recently approved treatment with 2 new medications in combination. The combination of Mekinist with Tafinlar worked better than Tefinlar alone. This may offer hope to those patients with advanced disease.
Here is my quote:
Gary Goldenberg, MD, an assistant professor of dermatology and pathology at Mount Sinai Medical Center in New York City, agrees. “[The new FDA approval] is an important step in treatment of patients with advanced melanoma, but prevention and early detection, however, are still the best option for patients.”
Other Blog Entries: